Document Detail

APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.
MedLine Citation:
PMID:  23212804     Owner:  NLM     Status:  Publisher    
To prospectively evaluate the potential influence of resistance to activated protein C (APC-resistance) on the initial inflammatory response, amputation rate and survival during 10 years of follow-up in patients with critical limb ischemia (CLI). Two hundred and fifty-six consecutive CLI patients were analyzed for APC-ratio, the Factor V Leiden mutation and inflammatory mediators and then prospectively followed for 10 years. Inflammatory mediators, amputation rate, morbidity and mortality were compared between patients with and without APC resistance. Of the 256 CLI patients, 35 (14 %) were heterozygotes and 2 (1 %) homozygotes for the Factor V gene mutation, whereas 219 (86 %) patients were non-APC resistant. No significant differences were found between APC resistant and non-APC resistant patients regarding inflammatory mediators. Non-APC resistant patients more often had infrainguinal atherosclerosis (172 [79 %] vs 22 [59 %]; p = 0.017). Amputation rate at 1 year did not differ. Furthermore, there were no significant differences between groups regarding 1-, 3-, 5-, or 10-year survival. APC resistance in patients with CLI was not related to inflammatory activity, and had no impact on limb salvage or rate of amputation or long-term mortality. APC-resistant CLI-patients less frequently had infrainguinal arteriosclerosis, however.
Ellis S Sampram; Anders Gottsäter; Bengt Lindblad; Peter J Svensson
Related Documents :
24055204 - Combined evaluation of nutrition and hydration in dialysis patients with bioelectrical ...
24282464 - A population-based study on the association between urinary calculi and kidney cancer.
24383834 - Ultrasonographic evaluation of synovial effusion and synovial proliferation pattern in ...
24594404 - Overactive bladder changes with time - a five-year longitudinal follow-up of the change...
20535514 - Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multip...
1748754 - Acute and chronic ischemia of the hand: pathophysiology, treatment, and prognosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Journal of thrombosis and thrombolysis     Volume:  -     ISSN:  1573-742X     ISO Abbreviation:  J. Thromb. Thrombolysis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502018     Medline TA:  J Thromb Thrombolysis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Vascular Center, Malmö University Hospital, University of Lund, 20502, Malmö, Sweden,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidenc...
Next Document:  Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients:...